Standout Papers
- Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study (2015)
- EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis (2018)
- Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis (2013)
Citation Impact
Citing Papers
Pathobiology of liver fibrosis: a translational success story
2015
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
2007 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Obesity alters gut microbial ecology
2005 Standout
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
Atorvastatin and fluvastatin are associated with dose‐dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES
2016
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
New frontiers in liver resection for hepatocellular carcinoma
2020
Bio-degradable highly fluorescent conjugated polymer nanoparticles for bio-medical imaging applications
2017
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
2015
Idiopathic pulmonary fibrosis
2017 Standout
ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase
2011
A view on drug resistance in cancer
2019 StandoutNature
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Hepatocellular carcinoma
2018 Standout
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Mechanisms of hepatic stellate cell activation
2017 Standout
Burden of liver diseases in the world
2018 Standout
Liver cirrhosis
2014
Ultrasound-targeted microbubble destruction optimized HGF-overexpressing bone marrow stem cells to repair fibrotic liver in rats
2020
Antithrombotic Therapy for VTE Disease
2016 Standout
Intensive Care Unit Management of Patients with Liver Failure
2014
miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis
2012
Induction and differentiation of human induced pluripotent stem cells into functional cardiomyocytes on a compartmented monolayer of gelatin nanofibers
2016
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4
2015
Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: Impact of exogenous neuropeptide Y
2012
Psoriasis
2021 Standout
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols
2021 StandoutNobel
Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats
2011
Gut microbiome and health: mechanistic insights
2022 Standout
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Antithrombotic Therapy for VTE Disease
2012 Standout
Acute kidney injury
2019 Standout
Portal hypertensive bleeding in cirrhosis
2016 Standout
Normal and Fibrotic Rat Livers Demonstrate Shear Strain Softening and Compression Stiffening: A Model for Soft Tissue Mechanics
2016
Non-alcoholic fatty liver disease
2021 Standout
Sepsis and septic shock
2018 Standout
Determinants and clinical implications of chromosomal instability in cancer
2018
A survey on deep learning in medical image analysis
2017 Standout
Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date
2019
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
2015
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Global burden of liver disease: 2023 update
2023 Standout
Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling
2020
Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome
2018
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation
2015
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Translating an Understanding of the Pathogenesis of Hepatic Fibrosis to Novel Therapies
2013
Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats
2015
Clinical states of cirrhosis and competing risks
2017
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
2020 Standout
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Hepatocellular carcinoma
2022 Standout
Bile acids: emerging role in management of liver diseases
2015
Cellular senescence: from physiology to pathology
2014 Standout
Machine learning for data-driven discovery in solid Earth geoscience
2019 StandoutScience
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
New advances in probing cell–extracellular matrix interactions
2017
Hepatocellular Carcinoma
2019 Standout
All-optical machine learning using diffractive deep neural networks
2018 StandoutScience
CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
2019
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR‐148a on tumor growth and phenotype and liver fibrosis
2015
Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers
2019
Resolution of liver fibrosis requires myeloid cell–driven sinusoidal angiogenesis
2014
Definitions, methods, and applications in interpretable machine learning
2019 Standout
Induction of autophagy and apoptosis by miR-148a through the sonic hedgehog signaling pathway in hepatic stellate cells.
2015
Nonalcoholic Fatty Liver Disease
2015 Standout
Gut Microbiota and Host Reaction in Liver Diseases
2015
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Works of Jonel Trebicka being referenced
Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
2010
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome
2018
Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-Up Study
2009
Vascular dysfunction in human and rat cirrhosis: Role of receptor-desensitizing and calcium-sensitizing proteins
2007
Pro-C5, a marker of true type V collagen formation and fibrillation, correlates with portal hypertension in patients with alcoholic cirrhosis
2015
Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis
2015
Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
2013
Direct visualization of cell division using high-resolution imaging of M-phase of the cell cycle
2012
Role of β3‐adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis†
2009
Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy
2015
Soluble TNF-Alpha-Receptors I Are Prognostic Markers in TIPS-Treated Patients with Cirrhosis and Portal Hypertension
2013
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase
2007
Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt
2011
Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction
2011
Novel role of nuclear receptor rev-erbα in hepatic stellate cell activation: Potential therapeutic target for liver injury
2014
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction
2011
The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
2015
Experimental liver fibrosis research: update on animal models, legal issues and translational aspects
2013
Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis
2009
Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats
2012
The microbiota in cirrhosis and its role in hepatic decompensation
2021
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
2016
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects
2012
Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis
2012
G-Protein–Coupled Receptor MrgD Is a Receptor for Angiotensin-(1–7) Involving Adenylyl Cyclase, cAMP, and Phosphokinase A
2016
Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension
2013
The carbon tetrachloride model in mice
2015
2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta‐analysis
2020
Shear‐wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study
2016